| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| R&D Expense | $5.0M | +0.8% | +1871.7% |
| SG&A Expense | $1.8M | -64.4% | -10.0% |
| Interest Expense | $17K | — | -99.2% |
| Net Income | -$7.1M | +25.4% | -228.7% |
| EPS (Basic) | -$0.14 | +33.3% | +89.8% |
| EPS (Diluted) | -$0.14 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.7M | -68.3% | -10.7% |
| Current Assets | $3.5M | -72.1% | +0.6% |
| Total Assets | $25.7M | -25.8% | +520.7% |
| Current Liabilities | $8.8M | -41.8% | +291.4% |
| Total Liabilities | $8.9M | -41.2% | +264.8% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$22.1M | — | -1068.5% |
| Capital Expenditures | $48K | — | — |
| Investing Cash Flow | -$1.3M | — | — |
| Financing Cash Flow | $13.4M | — | — |
| Free Cash Flow | -$22.1M | — | — |
| +74.1% |
| $16.8M |
| -13.7% |
| +889.9% |